# Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

> **NCT00136799** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 325 (actual)

## Conditions studied

- Mixed Dyslipidemia
- Hypercholesterolemia

## Interventions

- **DRUG:** Fluvastatin

## Key facts

- **NCT ID:** NCT00136799
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 325 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136799, "Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00136799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*